Diagnosis of Alzheimer's disease with cerebrospinal fluid tau protein and aspartate aminotransferase (multiple letters) [11]

Lancet

Volumn 351, Issue 9095, 1998, Pages 63-64

  Esmonde, T ^a   Riemenschneider, M ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; TAU PROTEIN; BIOLOGICAL MARKER;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; DEMENTIA; DIFFERENTIAL DIAGNOSIS; HUMAN; LETTER; MENTAL HEALTH; NEUROFIBRILLARY TANGLE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; CEREBROSPINAL FLUID; NOTE;

ALZHEIMER DISEASE; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; HUMANS; TAU PROTEINS;

EID: 0032477440     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(05)78061-2     Document Type: Letter

References (4)

1. M Riemenschneider K Buch M Schmolke A Kurz WG Guder Cerebrospinal protein tau is elevated in early Alzheimer's disease Neurosci Lett 212 1996 209 211
2. WA Munroe PC Southwick L Change Tau protein in cerebrospinal fluid as an aid in the diagnosis of Alzheimer's disease Ann Clin Lab Sci 25 1995 207 217
3. M Otto J Wiltfang H Tumani Elevated levels of tau protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease Neurosci Lett 225 1997 210 212
4. H Arai M Terajima M Miura Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease Ann Neurol 38 1995 649 652